Company profile: MedinCell
1.1 - Company Overview
Company description
- Provider of injectable slow-release drug expertise.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MedinCell
Lexaria Bioscience
HQ: Canada
Website
- Description: Provider of patented DehydraTECH technology that improves bio-absorption, reduces onset time, and enhances delivery of lipophilic drugs across the blood-brain barrier; out-licenses this platform and operates units focused on pharmaceuticals (hypertension, antiviral, epilepsy), oral non-combusted nicotine, hemp-derived ingredients, a Health Canada licensed lab for cannabinoid and other formulations, and nutraceutical CPG applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexaria Bioscience company profile →
Virpax Pharmaceuticals
HQ: United States
Website
- Description: Provider of intranasal and topical therapeutics for pain, epilepsy, and viral inhibition, including: Probudur, a single-injection liposomal bupivacaine for extended post-operative pain; Envelta, intranasal enkephalin for acute/chronic and cancer pain; NobrXiol, intranasal CBD for rare pediatric epilepsy; AnQlar, intranasal spray to inhibit influenza/SARS-CoV-2; and Epoladerm, topical diclofenac spray film for osteoarthritis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Virpax Pharmaceuticals company profile →
CeQur
HQ: Switzerland
Website
- Description: Provider of wearable insulin delivery solutions for people with diabetes, including the CeQur Simplicity insulin patch that delivers mealtime bolus insulin via a small, flexible cannula without injections. Offers a Patient Starter Kit with patches and a reusable inserter, the CeQur Cares support program, and the CeQur Simplicity Copay Savings Card. Works with physicians and centers to bring technology to patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CeQur company profile →
PLx Pharma
HQ: United States
Website
- Description: Provider of non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets, developing and commercializing these therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PLx Pharma company profile →
Liquidia
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for pulmonary hypertension. Portfolio includes investigational treprostinil products YUTREPIA (inhaled dry powder) and L606 (sustained-release liposomal via next-generation nebulizer) for PAH and PH-ILD; a fully substitutable generic treprostinil injection for PAH promoted with Sandoz; and PRINT Technology to create precise drug particles for enhanced lung delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liquidia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MedinCell
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MedinCell
2.2 - Growth funds investing in similar companies to MedinCell
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MedinCell
4.2 - Public trading comparable groups for MedinCell
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →